Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Pfizer

Status: Completed

Conditions: Renal Cell Carcinoma

Treatments: Procedure: nephrectomy

Study type: Observational

Funder types: Industry

Identifiers

NCT04309617

A6181230

Details and patient eligibility

About

This study aims at estimating the proportion of patients diagnosed with locoregional renal cell carcinoma who are at high risk for recurrence following nephrectomy, describe referral patterns, and characterize treatment in this population. Outcomes including estimation of the incidence of recurrence and disease-free interval following nephrectomy will be reported overall and among the subgroup off patients receiving adjuvant systemic therapy with sunitinib following nephrectomy.

Enrollment: 618 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must meet all of the following inclusion criteria to be eligible for data abstraction:

  • Diagnosed with locoregional RCC (no distant metastasis at the time of diagnosis)
  • Underwent a nephrectomy at Duke between 01 April 2014, and 31 December 2019 (final dates determined based on results from part 2 data collection)
  • Aged 18 years or older at nephrectomy

Exclusion criteria

• none

Trial design

618 participants in 1 patient group

patients with Renal Cell Carcinoma(RCC)

Description:

Patients diagnosed with RCC who received a nephrectomy between 01Apr2014 and 31Mar2019

Treatment:

Procedure: nephrectomy